15% OFF

Tesamorelin – 10mg/vial (Research Use Only)

Name: Tesamorelin – 10mg/vial (Research Use Only)
Brand: Portal to Wellness
SKU: 708
Price: 72 USD
Availability: InStock

— or subscribe to save 10% You save $12.71

Growth hormone–releasing hormone (GHRH) analog peptide studied in visceral adipose tissue research.

Availability: In stock

Volume pricing
3–4 vials — 5% off · 5–9 vials — 10% off · 10+ vials — 15% off
Applied automatically in the cart. Combines with a discount code up to 20% off in total, and stacks on top of the subscription discount.

Research Disclaimer: All products currently listed on this site are for research purposes only.

Ships in 1-2 Business Days Discreet, temperature-controlled packaging

Research Support Included Chat & email — our team knows the research

One-time purchase
Subscribe to save 10%

one time
Original price was: $84.71.Current price is: $64.80. / month — save 10%
Original price was: $84.71.Current price is: $64.80. every 3 weeks — save 10%

How the subscription works

Pick how often you want it. We email a reminder 7 days before each delivery is due, then the invoice itself.
Nothing is charged automatically. You pay each invoice the same way you pay any order — Zelle or crypto.
Every renewal is 10% off, and volume pricing still applies on top of that.
Cancel or pause from your account at any time. No minimum and no notice period.
Orders over $150 ship free, renewals included.

Research Grade ≥98% purity standard

Fast Fulfillment Ships in 1–2 days

Most reordered metabolic research product

Why Researchers Explore Tesamorelin – 10mg/vial (Research Use Only)

Backed by the ResearchRead: How Incretin and Growth-Hormone-Axis Compounds in the Literature →

Overview

Tesamorelin is a full-length synthetic analogue of endogenous growth hormone-releasing hormone (GHRH) consisting of the complete 44-amino acid GHRH sequence with a trans-3-hexenoic acid modification at the N-terminus that confers improved proteolytic stability. As the only FDA-approved GHRH analogue (approved as Egrifta for HIV-associated lipodystrophy), tesamorelin offers researchers both an extensive published clinical pharmacology literature and a robust preclinical dataset, making it the reference compound for GHRH biology in tissue-specific GH secretion and metabolic research.

What It Is

Tesamorelin is a 44-amino acid GHRH analogue (identical to human GHRH(1-44)) with a trans-3-hexenoic acid group conjugated at the N-terminal amino group, providing DPP-IV resistance. Molecular weight: approximately 5,135 Da. CAS number: 218949-48-5. Tesamorelin acts as a full agonist at the GHRH receptor (GHRHR), stimulating pulsatile GH release from anterior pituitary somatotrophs.

Key Research Applications

Full-length GHRH receptor agonism and downstream GH secretion kinetics research
Pituitary somatotroph physiology and GHRHR signaling pathway studies
GH pulsatility and IGF-1 axis response modeling in animal and clinical pharmacology
Visceral adipose tissue biology and adipogenesis/lipolysis regulation research
Comparative GHRH analogue pharmacology (tesamorelin vs. CJC-1295, Mod GRF 1-29)
HIV-associated lipodystrophy mechanistic and pharmacological modeling research
Metabolic syndrome, insulin sensitivity, and GH deficiency model studies
N-terminal peptide stabilization and DPP-IV resistance research in peptide chemistry

Technical Specifications

Amino Acids	44 (full-length GHRH with N-terminal modification)
Molecular Weight	~5,135 Da
CAS Number	218949-48-5
Mechanism	Full GHRH Receptor Agonist
Purity	≥98% (supplier specification)
Form	Lyophilized powder
Vial Size	10mg
Storage	−4 °F long-term

FOR RESEARCH USE ONLY. Not intended for human or veterinary consumption, medical diagnosis, treatment, or prevention of any disease or condition. This product has not been evaluated by the FDA or any regulatory agency. Must be handled by qualified research personnel in a compliant laboratory setting. These statements have not been evaluated by the Food and Drug Administration.

Not sure which compounds fit your research? Browse the Research Hub →